Clinical Trial Update: The DIOXXACT Trial(Diurnal IOP and OBF Xalatan vs Xalatan And Cosopt Trial) [Phase 4]

View source ↗

Summary

Completed Phase 4 trial comparing Xalatan alone versus Xalatan in combination with Cosopt to assess diurnal intraocular pressure in eye disease (glaucoma and oc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• Cosopt (dorzolamide/timolol)
• Xalatan (latanoprost)

Snippet

Sponsor: Maisonneuve-Rosemont Hospital | Conditions: Eye Disease | Phase 4 | Status: COMPLETED